Xstelos Holdings, Inc. Asset Turnover Ratio (XTLS), as of third quarter 2013, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Xstelos Holdings, Inc.  (XTLS)
 

Xstelos Holdings Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Xstelos Holdings, Inc. asset turnover ratio, the ability of Xstelos Holdings, Inc.'s assets to generate revenue in the third quarter 2013, increased sequentially to 0.25 in the third quarter (Sep 30 2013), yet the ratio remained below the average, as XTLS's position remain challenging.

Within sector 27 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2013 compared to the preceding quarter from 1242 to 3248.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XTLS Asset Turnover Ratio (Sep 30 2013)
III. Quarter		 (Jun 30 2013)
II. Quarter		 (Mar 31 2013)
I. Quarter		 (Dec 31 2012)
IV. Quarter		 (Sep 30 2012)
III. Quarter
Y / Y Asset Change -13.91 % 2.9 % 12.02 % - -
Y / Y Revenue Change -3.46 % 12.94 % -21.12 % - -
Asset Turnover Ratio (TTM) 0.25 0.24 0.24 0.26 0.23
XTLS's Total Ranking # 3248 # 1242 # 1242 # 1165 # 0
Seq. Asset Change -2.65 % -1.88 % -0.83 % -9.11 % 16.35 %
Seq. Revenue Change -3.36 % 16.35 % -38.91 % 40.54 % 13.06 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 314
Overall Market # 3248

Asset Turnover Ratio Statistics
High Average Low
4.32 4.12 4
(Sep 30 2013)   (Mar 31 2013)




XTLS Company Profile • Back to XTLS Efficiency Comparisons • Compare XTLS Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2013, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2013 Assets at quarter ending Sep 30 2013
Conmed Corporation  0.70 $ 760.506  Millions$ 1,083.598  Millions
Quidelortho Corp  0.70 $ 179.165  Millions$ 257.449  Millions
Eli Lilly And Company  0.69 $ 23,261.600  Millions$ 33,472.650  Millions
Synthorx, Inc.  0.69 $ 503.106  Millions$ 724.575  Millions
Cytosorbents Corporation  0.69 $ 2.231  Millions$ 3.222  Millions
Biospecifics Technologies Corp  0.69 $ 13.903  Millions$ 20.192  Millions
Becton Dickinson And Company  0.69 $ 8,054.231  Millions$ 11,748.852  Millions
Abbvie Inc   0.68 $ 18,885.000  Millions$ 27,584.750  Millions
Retractable Technologies Inc  0.68 $ 31.283  Millions$ 45.926  Millions
Davita Inc   0.68 $ 11,178.694  Millions$ 16,428.725  Millions
Resmed Inc   0.68 $ 1,532.388  Millions$ 2,264.545  Millions
Rti Surgical Holdings Inc   0.67 $ 182.080  Millions$ 271.692  Millions
Cambrex Corp  0.67 $ 285.070  Millions$ 426.744  Millions
Cutera Inc   0.67 $ 74.888  Millions$ 112.170  Millions
Enovis Corp  0.67 $ 4,063.228  Millions$ 6,101.084  Millions
Baxter International Inc   0.65 $ 14,644.000  Millions$ 22,427.250  Millions
Wearable Health Solutions, Inc.  0.65 $ 0.693  Millions$ 1.061  Millions
Repligen Corp  0.65 $ 71.601  Millions$ 110.610  Millions
Accuray Incorporated  0.65 $ 309.867  Millions$ 479.835  Millions
Nephros Inc   0.64 $ 1.882  Millions$ 2.926  Millions
Agilent Technologies inc   0.64 $ 6,782.000  Millions$ 10,551.000  Millions
Allergan plc  0.64 $ 6,124.900  Millions$ 9,562.350  Millions
Titan Pharmaceuticals Inc   0.64 $ 12.829  Millions$ 20.197  Millions
Stryker Corp  0.63 $ 8,890.000  Millions$ 14,140.000  Millions
Soligenix inc   0.63 $ 4.058  Millions$ 6.470  Millions
Bio rad Laboratories Inc   0.62 $ 2,103.859  Millions$ 3,414.196  Millions
Brookdale Senior Living Inc   0.62 $ 2,857.481  Millions$ 4,640.490  Millions
Cryoport inc   0.61 $ 1.743  Millions$ 2.847  Millions
United Therapeutics Corporation  0.61 $ 1,071.784  Millions$ 1,757.320  Millions
Biogen Inc   0.60 $ 6,384.290  Millions$ 10,596.669  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.